Medical Device Testing Services Market (By Service: Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing [Bio-Burden Determination, Pyrogen and Endotoxin Testing, Sterility Test and Validation, Anti-microbial Activity Testing, Other Services], Package Validation; By Phase: Preclinical [Antimicrobial Wound Dressings, Medical Coatings, Others], Clinical) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global medical device testing service market size is anticipated to around USD 14.2 billion by 2026, this market is anticipated to grow with 12.2% CAGR during the forecast time period.The medical device testing service market is driven by growing spending in preclinical phase of medical devices.

Market Dynamics

Rise of drug device combination, personalized medication, artificial intelligence (AI), wearables and focus on real-time patient monitoring resulted in complex medical devices ecosystem. To match these factors, gadgets now have to undergo shear testing in augmented conditions to obtain marketing approval. Conducting these tests in-house needs a lot of time, cost, and labour; this is anticipated to increase the need for outsourcing of these services thereby increasing the market development.

Market Insights

Growing need for in-vitro tests is also anticipated to boost the industry, as a lot of CROs are emerging novel methods to replace the traditional in-vivo tests that require animal testing. Development in the growth and standardization of novel in vitro test approaches; particularly for sensitization, cytotoxicity, and irritation that are the basic test required for all the medical device is also expected to support industry development.

Market Segmentation

Market By Service

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bio-Burden Determination
    • Pyrogen and Endotoxin Testing
    • Sterility Test and Validation
    • Anti-microbial Activity Testing
    • Other Services
  • Package Validation

Market By Phase

  • Preclinical
    • Antimicrobial Wound Dressings
    • Medical Coatings
    • Others
  • Clinical

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Asia Pacific captures the largest market share in the medical device testing services market due to augmented outsourcing in nations, for instance, as India and China. Contract Research Organizations (CROs) are spending heavily in emerging nations of APAC due to lower cost and easy accessibility of trained labour. North America captures the second-largest share in 2018 and is anticipated to observer important development during the forecast timeframe.

This development can be credited to the fact that it is one of the top industrial hubs of complex, high-end, and reliable medical gadgets. Many CROs have a developed business in the region that delivers complete range of testing services for businesses. The Europe region is led by nations (Germany Spain, U.K., France, and Italy) EU5. Increasing demand for cost cutting and growing difficulty in product designing are anticipated to be the major industry drivers.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the medical device testing servicesmarket are Medical Device Testing Services, Toxikon, Inc., American Preclinical Services LLC, SGS SA, Charles River Laboratories International, Inc., Eurofins Scientific, LLC, Sterigenics International LLC, Intertek Group PLC, North American Science Associates, Inc., WuXiAppTec Group, and Pace Analytical Services, LLC.


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary